Cover Image

Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study

Objectives To assess the risk of flare and damage accrual after tapering glucocorticoids (GCs) in modified serologically active clinically quiescent (mSACQ) patients with systemic lupus erythematosus (SLE). Methods Data from a 12-country longitudinal SLE cohort, collected prospectively between 2013...

Full description

Saved in:
Bibliographic Details
Main Authors: Katsumata, Yasuhiro, Inoue, Eisuke, Harigai, Masayoshi, Cho, Jiacai, Louthrenoo, Worawit, Hoi, Alberta, Golder, Vera, Lau, Chak Sing, Lateef, Aisha, Chen, Yi-Hsing, Luo, Shue-Fen, Wu, Yeong-Jian Jan, Hamijoyo, Laniyati, Li, Zhanguo, Sockalingam, Sargunan, Navarra, Sandra, Zamora, Leonid, Hao, Yanjie, Zhang, Zhuoli, Chan, Madelynn, Oon, Shereen, Ng, Kristine, Kikuchi, Jun, Takeuchi, Tsutomu, Goldblatt, Fiona, O'Neill, Sean, Tugnet, Nicola, Law, Annie Hui Nee, Bae, Sang-Cheol, Tanaka, Yoshiya, Ohkubo, Naoaki, Kumar, Sunil, Kandane-Rathnayake, Rangi, Nikpour, Mandana, Morand, Eric F.
Format: Article
Published: BMJ Publishing Group 2024
Subjects:
R Medicine (General)
Online Access:http://eprints.um.edu.my/47039/
https://doi.org/10.1136/ard-2023-225369
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items